Lemin Hong
Nantong, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Downregulated expression of dual-specificity phosphatase-1 in multiple myeloma as a predictor of poor survival outcomes.
Journal: Hematology (Amsterdam, Netherlands)
Published: March 13, 2025
POEMS syndrome: origination from clonal plasma cells or B cells?
Journal: Hematology (Amsterdam, Netherlands)
Published: March 10, 2023
Increased expression of CEP72 predicts poor prognosis in multiple myeloma.
Journal: International journal of laboratory hematology
Published: October 27, 2022
The Prognostic Role of Cyclin D1 in Multiple Myeloma: A Systematic Review and Meta-Analysis.
Journal: Technology in cancer research & treatment
Published: January 31, 2022
The Mutation of BTG2 Gene Predicts a Poor Outcome in Primary Testicular Diffuse Large B-Cell Lymphoma.
Journal: Journal of inflammation research
Published: September 26, 2021
The role of cystatin C in multiple myeloma.
Journal: International journal of laboratory hematology
Published: April 20, 2021
The role of cystatin C as a proteasome inhibitor in multiple myeloma.
Journal: Hematology (Amsterdam, Netherlands)
Published: November 30, 2020
Therapeutic status and the prospect of CRISPR/Cas9 gene editing in multiple myeloma.
Journal: Future oncology (London, England)
Published: April 28, 2020
ANXA7 promotes the cell cycle, proliferation and cell adhesion-mediated drug resistance of multiple myeloma cells by up-regulating CDC5L.
Journal: Aging
Published: March 12, 2020
Type 2 diabetes mellitus does not increase the risk of multiple myeloma: a systematic review and meta-analysis.
Journal: Translational cancer research
Published: December 13, 2019
Entire ABL1 Gene Deletion Without BCR/ABL1 Rearrangement in a Female Patient with B-Cell Precursor Acute Lymphoblastic Leukemia.
Journal: OncoTargets and therapy
Published: November 12, 2019
Last Updated: 09/26/2026